Harbor Capital Advisors, Inc. Beam Therapeutics Inc. Transaction History

Harbor Capital Advisors, Inc.

  • $2.29 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 08, 2024
BUY
$17.69 - $30.76 $70,848 - $123,193
4,005 Added 12.96%
34,918 $950,000
Q3 2023

Oct 20, 2023
BUY
$23.01 - $32.46 $110,309 - $155,613
4,794 Added 18.35%
30,913 $743,000
Q2 2023

Jul 11, 2023
BUY
$29.32 - $35.99 $765,809 - $940,022
26,119 New
26,119 $833,000

Others Institutions Holding BEAM

# of Institutions
238
Shares Held
76.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.95B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email